(NASDAQ: VANI) Vivani Medical's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 6.58%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 54.34%.
Vivani Medical's earnings in 2025 is -$25,537,000.On average, 1 Wall Street analyst forecast VANI's earnings for 2025 to be -$27,252,195, with the lowest VANI earnings forecast at -$27,252,195, and the highest VANI earnings forecast at -$27,252,195.
In 2026, VANI is forecast to generate -$22,512,683 in earnings, with the lowest earnings forecast at -$22,512,683 and the highest earnings forecast at -$22,512,683.